Review
Open access
Aug 2026
Targeting immune checkpoint B7-H6 in cancer immunotherapy
Current findings position B7-H6 as a promising immuno-oncologic target at the intersection of immune surveillance, immune escape, and malignant progression, warranting continued investigation as a next-generation therapeutic axis in cancer immunotherapy.
Ziyi Yang, Qi Zhao
· Cancer Biome and Targeted Th... · 0 citations